Page last updated: 2024-10-24

celiprolol and Carotid Artery Diseases

celiprolol has been researched along with Carotid Artery Diseases in 1 studies

Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.

Carotid Artery Diseases: Pathological conditions involving the CAROTID ARTERIES, including the common, internal, and external carotid arteries. ATHEROSCLEROSIS and TRAUMA are relatively frequent causes of carotid artery pathology.

Research Excerpts

ExcerptRelevanceReference
"The angiotensinogen M235T polymorphism has been linked to hypertension and cardiovascular disease."5.10Angiotensinogen gene M235T polymorphism and reduction in wall thickness in response to antihypertensive treatment. ( Boutouyrie, P; Bozec, E; Dabire, H; Fassot, C; Jeunemaitre, X; Lacolley, P; Laurent, S; Tropeano, AI, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bozec, E1
Fassot, C1
Tropeano, AI1
Boutouyrie, P1
Jeunemaitre, X1
Lacolley, P1
Dabire, H1
Laurent, S1

Trials

1 trial available for celiprolol and Carotid Artery Diseases

ArticleYear
Angiotensinogen gene M235T polymorphism and reduction in wall thickness in response to antihypertensive treatment.
    Clinical science (London, England : 1979), 2003, Volume: 105, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Angiotensinogen; Antihypertensive Agents; Caro

2003